These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues. Tjernberg P; Vos HL; Castaman G; Bertina RM; Eikenboom JC J Thromb Haemost; 2004 Feb; 2(2):257-65. PubMed ID: 14995987 [TBL] [Abstract][Full Text] [Related]
9. Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor. Daidone V; Barbon G; Pontara E; Cattini GM; Gallinaro L; Zampese E; Pizzo P; Casonato A Thromb Haemost; 2014 Dec; 112(6):1159-66. PubMed ID: 25230768 [TBL] [Abstract][Full Text] [Related]
10. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response. Kat M; Margadant C; Voorberg J; Bierings R FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944 [TBL] [Abstract][Full Text] [Related]
11. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation. Castaman G; Giacomelli SH; Jacobi PM; Obser T; Budde U; Rodeghiero F; Schneppenheim R; Haberichter SL J Thromb Haemost; 2012 May; 10(5):951-8. PubMed ID: 22429825 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease. Tjernberg P; Vos HL; Spaargaren-van Riel CC; Luken BM; Voorberg J; Bertina RM; Eikenboom JC Thromb Haemost; 2006 Dec; 96(6):717-24. PubMed ID: 17139364 [TBL] [Abstract][Full Text] [Related]
13. Weibel-Palade bodies: a window to von Willebrand disease. Valentijn KM; Eikenboom J J Thromb Haemost; 2013 Apr; 11(4):581-92. PubMed ID: 23398618 [TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells. Bowman M; Casey L; Selvam SN; Lima PDA; Rawley O; Hinds M; Tuttle A; Grabell J; Iorio A; Walker I; Lillicrap D; James P J Thromb Haemost; 2022 Jul; 20(7):1599-1609. PubMed ID: 35466528 [TBL] [Abstract][Full Text] [Related]
15. How to roll an endothelial cigar: the biogenesis of Weibel-Palade bodies. Michaux G; Cutler DF Traffic; 2004 Feb; 5(2):69-78. PubMed ID: 14690496 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. Wang JW; Bouwens EA; Pintao MC; Voorberg J; Safdar H; Valentijn KM; de Boer HC; Mertens K; Reitsma PH; Eikenboom J Blood; 2013 Apr; 121(14):2762-72. PubMed ID: 23426949 [TBL] [Abstract][Full Text] [Related]
17. The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients. Pagliari MT; Baronciani L; Cordiglieri C; Colpani P; Cozzi G; Siboni SM; Peyvandi F Haemophilia; 2022 Mar; 28(2):292-300. PubMed ID: 35064738 [TBL] [Abstract][Full Text] [Related]
19. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Bodó I; Katsumi A; Tuley EA; Eikenboom JC; Dong Z; Sadler JE Blood; 2001 Nov; 98(10):2973-9. PubMed ID: 11698279 [TBL] [Abstract][Full Text] [Related]
20. Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells. van den Biggelaar M; Bouwens EA; Voorberg J; Mertens K PLoS One; 2011; 6(8):e24163. PubMed ID: 21909383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]